Moderna founder launches Apriori with $50M to stay ahead of virus variants

Moderna founder launches Apriori with $50M to stay ahead of virus variants

Source: 
BioPharma Dive
snippet: 

Flagship Pioneering, a creator of new biotech companies and founder of COVID-19 vaccine maker Moderna, announced Monday the launch of an infectious disease startup called Apriori Bio.